News

Biofilms are protective layers bacteria build in the sinuses that can make colonization stubborn. Here is what biofilm disruptors are, the ingredients commonly discussed (EDTA, xylitol, surfactants), and how to think about them sensibly.

MARCoNS is discussed in terms of antibiotics, biofilm disruption, nasal-microbiome support, and addressing the underlying exposure. This overview explains how the approaches are described in the literature — for discussion with your practitioner.

MARCoNS colonization is often discussed alongside fatigue, brain fog, chronic sinus congestion, and other symptoms tied to CIRS and mold illness. Here is what people commonly report, why the picture is complicated, and how it is evaluated.

How a decades-old chelating agent is gaining renewed attention for its role in biofilm disruption and microbial management.

A recently published review in Frontiers in Antibiotics examined the growing body of research surrounding ethylenediaminetetraacetic acid (EDTA), one of the most widely used chelating agents in medicine, industry, and microbiology. The authors concluded that EDTA possesses unique antimicrobial and antibiofilm properties and may enhance the effectiveness of a variety of natural compounds and antimicrobial agents when used in combination.

MARCoNS stands for Multiple Antibiotic-Resistant Coagulase-Negative Staphylococci — a group of staph bacteria that can quietly colonize the deep nasal passages. Here is what the term means, why it comes up in mold-illness and CIRS conversations, and how it is tested.

A new study of 188 CIRS patients found that successful MARCoNS clearance was associated with significantly higher alpha-MSH levels. Discover what this research reveals about the nasal microbiome, chronic inflammation, mold illness, and recovery from Chronic Inflammatory Response Syndrome.